Analyst Downgrades – INC Research Holdings (NASDAQ:INCR) Stock Gets Downgraded By SunTrust Banks, Inc. from Buy to Hold

17

Analyst Ratings For INC Research Holdings (NASDAQ:INCR)

Today, INC Research Holdings (NASDAQ:INCR) stock was downgraded by SunTrust Banks, Inc. from Buy to Hold with a price target of $48.00.

There are 5 hold ratings, 5 buy ratings on the stock.

The current consensus rating on INC Research Holdings (NASDAQ:INCR) is Buy (Score: 2.50) with a consensus target price of $50.63 per share, a potential 11.63% upside.

Some recent analyst ratings include

  • 3/20/2017-SunTrust Banks, Inc. was Downgraded by analysts at SunTrust Banks, Inc. from a “Buy ” rating to a ” Hold” rating. They now have a $48.00 price target on the stock.
  • 3/1/2017-William Blair Reiterated Rating of Outperform.
  • 3/1/2017-Goldman Sachs Group Inc was Downgraded by analysts at Goldman Sachs Group Inc from a “Conviction-Buy ” rating to a ” Buy” rating. They now have a $51.00 price target on the stock.
  • 2/28/2017-Jefferies Group LLC Reiterated Rating of Buy.
  • 12/19/2016-First Analysis initiated coverage with a Equal rating.
  • 6/20/2016-Credit Suisse Group AG initiated coverage with a Outperform rating.
  • 5/22/2016-KeyCorp Reiterated Rating of Hold.

Dividend information for INC Research Holdings (NASDAQ:INCR)

.
Recent Insider Trading Activity For INC Research Holdings (NASDAQ:INCR)
INC Research Holdings (NASDAQ:INCR) has insider ownership of 1.70% and institutional ownership of 99.79%.

  • On 3/3/2017 Alistair Macdonald, CEO, sold 8,828 with an average share price of $45.00 per share and the total transaction amounting to $397,260.00. View SEC Filing
  • On 1/20/2017 Alistair Macdonald, CEO, sold 1,375 with an average share price of $50.50 per share and the total transaction amounting to $69,437.50. View SEC Filing
  • On 1/20/2017 Christopher L Gaenzle, CAO, sold 1,186 with an average share price of $50.09 per share and the total transaction amounting to $59,406.74. View SEC Filing
  • On 1/19/2017 Gregory S Rush, VP, sold 2,907 with an average share price of $50.57 per share and the total transaction amounting to $147,006.99. View SEC Filing
  • On 1/5/2017 Alistair Macdonald, CEO, sold 14,840 with an average share price of $52.19 per share and the total transaction amounting to $774,499.60. View SEC Filing
  • On 9/30/2016 Gregory S Rush, VP, sold 35,503 with an average share price of $44.70 per share and the total transaction amounting to $1,586,984.10. View SEC Filing
  • On 9/27/2016 D. Jamie Macdonald, CEO, sold 53,970 with an average share price of $44.30 per share and the total transaction amounting to $2,390,871.00. View SEC Filing

About INC Research Holdings (NASDAQ:INCR)
INC Research Holdings, Inc. is a global contract research organization (CRO). The Company is focused on Phase I to Phase IV clinical development services for the biopharmaceutical and medical device industries. The Company operates through two segments: Clinical Development Services and Phase I Services. The Company’s Clinical Development Services segment offers all clinical development services, including full-service global studies, as well as ancillary services, such as clinical monitoring, investigator recruitment, patient recruitment, data management, study reports to assist customers with their drug development process, quality assurance audits and specialized consulting services. The Company’s Phase I Services segment focuses on clinical development services for Phase I trials, which include scientific exploratory medicine, first-in-human studies through proof-of-concept stages and support for Phase I studies in established compounds.

Recent Trading Activity for INC Research Holdings (NASDAQ:INCR)
Shares of INC Research Holdings closed the previous trading session at 45.35 down -0.95 -2.05% with 979,892 shares trading hands.

An ad to help with our costs